Skip to main content
SpringerLink
Log in

Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization

  • Review Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Pediatric rheumatic diseases (PRDs) are rare conditions associated with significant sequelae affecting the quality of life and long-term outcome. The research aimed at studying new therapeutic approaches is difficult because of logistic, methodological and ethical problems.

Data sources

To address these problems, two international networks, the Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Pediatric Rheumatology International Trials Organization (PRINTO) were established. The two networks share the goal to promote, facilitate and conduct high quality research for PRDs.

Results

The PRINTO and PRCSG networks have standardized the evaluation of response to therapy in juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus, and juvenile dermatomyositis, drafted clinical remission criteria in JIA, and provided cross-cultural adapted and validated quality of life instruments including the Childhood Health Assessment Questionnaire and the Child Health Questionnaire into 32 different languages. In this paper we reviewed how the networks of the PRINTO and PRCSG have created the basic premises for the best future assessment of PRDs.

Conclusions

The PRINTO and PRCSG networks can be regarded as a model for international cooperation or collaboration in other pediatric subspecialties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allaire SH, DeNardo BS, Szer IS, Meenan RF, Schaller JG. The economic impacts of juvenile rheumatoid arthritis. J Rheumatol 1992;19:952–955.

    PubMed  CAS  Google Scholar 

  2. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767–778.

    Article  PubMed  CAS  Google Scholar 

  3. Ruperto N, Levinson JE, Ravelli A, Shear ES, Tague BL, Murray K, et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol 1997;24:945–951.

    PubMed  CAS  Google Scholar 

  4. Ruperto N, Ravelli A, Levinson JE, Shear ES, Murray K, Tague BL, et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol 1997;24:952–958.

    PubMed  CAS  Google Scholar 

  5. Gutiérrez-Suárez R, Ruperto N, Gastaldi R, Pistorio A, Felici E, Burgos-Vargas R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006;54:2989–2996.

    Article  PubMed  Google Scholar 

  6. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394–398.

    Article  PubMed  CAS  Google Scholar 

  7. Schechter C. The use of placebo controls. N Engl J Med 1995;332:60–61.

    Article  PubMed  CAS  Google Scholar 

  8. Taubes G. Medical research: use of placebo controls in clinical trials disputed. Science 1995;267:25–26.

    Article  PubMed  CAS  Google Scholar 

  9. Reiff A, Shaham B, Wood BP, Bernstein BH, Stanley P, Szer IS. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol 1995;13:113–118.

    PubMed  CAS  Google Scholar 

  10. Wallace CA, Sherry DD. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J Rheumatol 1992;19:1604–1607.

    PubMed  CAS  Google Scholar 

  11. Miller LC, Sisson BA, Tucker LB, DeNardo BA, Schaller JG. Methotrexate treatment of recalcitrant childhood dermatomyositis. Arthritis Rheum 1992;35:1143–1149.

    Article  PubMed  CAS  Google Scholar 

  12. Lovell DJ, Giannini EH, Brewer EJ. Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis. Arthritis Rheum 1984;27:1433–1437.

    Article  PubMed  CAS  Google Scholar 

  13. Brewer EJ, Giannini EH. Methodology and studies of children with juvenile rheumatoid arthritis. J Rheumatol 1982;9:107–139.

    Google Scholar 

  14. Brewer EJ, Giannini EH. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. I. Design. J Rheumatol 1982;9:109–113.

    PubMed  Google Scholar 

  15. Giannini EH, Brewer EJ. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data. J Rheumatol 1982;9:114–122.

    PubMed  CAS  Google Scholar 

  16. Giannini EH. The N of 1 trials design in the rheumatic diseases. Arthritis Care Res 1988;1:109–115.

    Article  Google Scholar 

  17. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Semin Arthritis Rheum 1993;23:34–46.

    Article  PubMed  CAS  Google Scholar 

  18. Giannini EH, Brewer EJ, Person DA. Auranofin in the treatment of juvenile rheumatoid arthritis. J Pediatr 1983;102:138–141.

    Article  PubMed  CAS  Google Scholar 

  19. Brewer EJ, Giannini EH, Kuzmina N, Alekseev L. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis: Results of the U.S.A.-U.S.S.R double-blind, placebo controlled trial. N Engl J Med 1986;314:1269–1276.

    PubMed  CAS  Google Scholar 

  20. Giannini EH, Brewer EJ Jr, Kuzmina N, Shaikov A, Wallin B. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children’s Study Group. Arthritis Rheum 1990;33:466–476.

    Article  PubMed  CAS  Google Scholar 

  21. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med 1992;326:1043–1409.

    PubMed  CAS  Google Scholar 

  22. Lovell DJ, Giannini EH, Reiff A, Cawkwell D, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763–769.

    Article  PubMed  CAS  Google Scholar 

  23. Advisory Council of PRINTO. Bylaws of the “Paediatric Rheumatology International Trials Organisation—PRINTO”. First ed. June 15th, 1997. Second ed. October 1st, 2003. Available at www.printo.it (January 25, 2008).

  24. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004;16:566–570.

    Article  PubMed  Google Scholar 

  25. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202.

    PubMed  CAS  Google Scholar 

  26. Ruperto N, Ravelli A, Falcini F, Lepore L, De Sanctis R, Zulian F, et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998;57:38–41.

    Article  PubMed  CAS  Google Scholar 

  27. Albornoz MA. ACR formally adopts improvement criteria for juvenile arthritis (ACR Pediatric 30). ACR News 2002;21:3.

    Google Scholar 

  28. Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SKF, Falcini F, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50:2191–2201.

    Article  PubMed  CAS  Google Scholar 

  29. Martini A, Ruperto N, for the Paediatric Rheumatology International Trials Organization (PRINTO). Quality of life in juvenile idiopathic arthritis patients compared to healthy children. Clin Exp Rheumatol 2001;19:S1–S172.

    PubMed  Google Scholar 

  30. Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 2001;19:S1–S9.

    PubMed  CAS  Google Scholar 

  31. Pagava K, Ruperto N, Shalamberidze L, Mshvidobadze N, Paediat Rheumatology Int Trials Or. The Georgian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S66–S70.

    PubMed  CAS  Google Scholar 

  32. Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004;51:458–464.

    Article  PubMed  Google Scholar 

  33. Gutierrez-Suarez R, Pistorio A, Cespedes CA, Norambuena X, Flato B, Rumba I, et al. Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology 2007;46:314–320.

    Article  PubMed  CAS  Google Scholar 

  34. Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM, et al. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. Arthritis Rheum 2007;57:35–43.

    Article  PubMed  Google Scholar 

  35. Apaz M, Pistorio A, Ravelli A, Trail L, Cuttica R, Sato J, et al. Health related quality of life of patients with juvenile dermatomyositis. The PRINTO multinational quality of life cohort study. Ann Rheum Dis 2006;65:244.

    Google Scholar 

  36. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452–1459.

    Article  Google Scholar 

  37. Ruperto N, Ravelli A, Cuttica R, Espada G, Ozen S, Porras O, et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005;52:2854–2864.

    Article  PubMed  Google Scholar 

  38. Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al. The provisional Pediatric Rheumatology International Trial Organization/American College of Rheumatology/European League Againts Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008;59:4–13.

    Article  PubMed  Google Scholar 

  39. Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S, et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement. Arthritis Rheum 2006;55:355–363.

    Article  PubMed  Google Scholar 

  40. Ruperto N, Garcia-Munitis P, Villa L, Pesce M, Aggarwal A, Fasth A, et al. PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatricrheumatology.printo.it. Ann Rheum Dis 2005;64:1101–1106.

    Article  PubMed  CAS  Google Scholar 

  41. Hirsch R. Pediatric rheumatology: a call to action. Curr Opin Rheumatol 2004;15:571.

    Article  Google Scholar 

  42. Bandeira M, Falcone A, Pistorio A, Ruperto N, Magni-Manzoni S, Buoncompagni A, et al. Weighting improves the information provided by joint counts on the severity of arthritis and its impact on patients’ well-being in juvenile idiopathic arthritis. Rheumatology 2006;45:343–347.

    Article  PubMed  CAS  Google Scholar 

  43. Ferriani VPL, Ruperto N, Pistorio A, Oliveira S, Pilkington C, Magalhaes C, et al. Toward the development of a new PRINTO disease activity index for juvenile dermatomyositis. I. Selection of the candidate items based on the analysis of 284 patients. Ann Rheum Dis 2006;65:250.

    Google Scholar 

  44. Garcia-Munitis P, Bandeira M, Pistorio A, Magni-Manzoni S, Ruperto N, Schivo A, et al. Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis Rheum 2006;55:177–183.

    Article  PubMed  Google Scholar 

  45. Sztajnbok F, Coronel-Martinez DL, az-Maldonado A, Novarini C, Pistorio A, Viola S, et al. Discordance between physician’s and parent’s global assessments in juvenile idiopathic arthritis. Rheumatology 2006;46:141–145.

    Article  PubMed  Google Scholar 

  46. Tsitsami E, Bozzola E, Magni-Manzoni S, Viola S, Pistorio A, Ruperto N, et al. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. Arthritis Rheum 2003;49:488–493.

    Article  PubMed  Google Scholar 

  47. Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290–2294.

    PubMed  Google Scholar 

  48. Connor JD. A look at the future of pediatric therapeutics: an investigator’s perspective of the new pediatric rule. Pediatrics 1999;104:610–613.

    PubMed  CAS  Google Scholar 

  49. Food and Drug Administration (FDA). Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biologic products in pediatrics patients (21 CFR Parts 201, 312, 314, and 601). Federal Register 1998;63(231).

  50. Ruperto N, Martini A. Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children. BMJ 2000;320:1210–1211.

    Article  PubMed  CAS  Google Scholar 

  51. Regulation (EC) no 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official J Eur Union 2006;378:1–19.

  52. Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticularcourse juvenile rheumatoid arthritis. Arthritis Rheum 2007;56:3096–3106.

    Article  PubMed  CAS  Google Scholar 

  53. Ruperto N, Lovell DJ, Prieur AM, Paz E, Rubio Perez NE, Silva CA, et al. Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA). Lancet. In Press 2008.

  54. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Nemcova D, et al. 48-week data from the study of adalimumab in children with juvenile rheumatoid arthritis (JRA). N Engl J Med. In Press 2008.

Download references

Author information

Authors and Affiliations

  1. Genova, Italy

    Nicolino Ruperto & Alberto Martini

  2. IRCCS Istituto G. Gaslini, Pediatria II, Reumatologia and University of Genoa, Genoa, Italy

    Nicolino Ruperto & Alberto Martini

Authors
  1. Nicolino Ruperto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolino Ruperto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruperto, N., Martini, A. Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization. World J Pediatr 4, 186–191 (2008). https://doi.org/10.1007/s12519-008-0034-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-008-0034-6

Key words

Search

Navigation